Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04029623 · ClinicalTrials.gov registry record · NA
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
A NA study of Prodromal Alzheimer's Disease, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT04029623 is a NA study of Prodromal Alzheimer's Disease that is actively recruiting participants, run by Emory University. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04029623, a NA study of Prodromal Alzheimer's Disease, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Interventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing and treating Alzheimer's disease (AD). Functional decline in AD is severely impacted by impaired ability to do physical actions while having to make decisions and concentrating, something scientists call motor-cognitive integration. Combined motor and cognitive training has been recommended for people with early AD, thus this study will use partnered, rhythmic rehabilitation (PRR), as an intervention to simultaneously target cardiovascular, social and motor-cognitive domains important to AD. PRR is moderate intensity, cognitively-engaging social dance that targets postural control systems, involves learning multiple, varied stepping and rhythmic patterns, and fosters tactile communication of motor goals between partners, enhancing social interaction's effect on cognition. Previous research demonstrates that PRR classes are safe and result in no injurious falls. This study is a 12-month long Phase II single- blind randomized clinical trial using PRR in 66 patients with early AD. Participants with early AD will be randomly assigned to participate in PRR or a walking program for three months of biweekly sessions, followed by nine months of weekly sessions of PRR or walking. The overarching hypothesis is that PRR is safe, tolerable and associated with improved motor-cognitive function, and brain (neuronal), vascular (blood vessels) and inflammatory biomarkers that might affect function.
Conditions Studied
Interventions
- OTHER Partnered Rhythmic Rehabilitation (PRR)
- OTHER Group walking (WALK)
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04029623
The ClinicalTrials.gov registry entry for NCT04029623 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prodromal Alzheimer's Disease appearing as the primary indexed condition, and to 2 interventions - of which Partnered Rhythmic Rehabilitation (PRR) is the first listed.
NCT04029623 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04029623 about?
NCT04029623 is a clinical study titled "Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease". Interventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing and treating Alzheimer's disease (AD). Functional decline in AD is severely impacted by impaired ability to do physical actions while having to...
What is the current status of trial NCT04029623?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2019-10-29. Estimated completion is 2026-07.
What conditions does trial NCT04029623 study?
This clinical trial studies the following conditions: Prodromal Alzheimer's Disease.
What interventions are being tested in trial NCT04029623?
The interventions under investigation include: Partnered Rhythmic Rehabilitation (PRR) (OTHER), Group walking (WALK) (OTHER).
Who is sponsoring clinical trial NCT04029623?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04029623 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prodromal Alzheimer's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.